Bioburden Testing Market size is projected to experience significant growth from 2022 to 2028. Proliferating medical and pharmaceutical industry along with growing concerns for health and safety among people will fuel the market growth during the forecast timeline. Bioburden is the number of microbial organisms living on an unsterilized surface, and the determination of microbial contamination on or inside a product surface is called bioburden testing.
Bioburden testing or microbial limit testing is performed during the operation and handling of several pharmaceutical and medical products to keep the microbial levels in check and meet the quality and safety requirements.
Increasing adoption of microbial testing in the manufacturing and routine monitoring of food & beverages, medical equipment, pharmaceuticals, and cosmetics will foster the growth trends in the industry. Moreover, the risk of disease spread in places like jails, prisons, and healthcare centers will push the demand for bioburden testing in these places. Technological advancement and growing R&D activities leading to new product innovations in the field of pharmaceuticals and biotechnology will further support the industry expansion in the forthcoming years.
Based on application, the raw material testing segment may record an appreciable growth rate during the forecast timeframe. Raw material testing is performed individually on the raw materials of foods and drugs before their manufacturing process takes place to ensure the purity, quality, and identity of raw materials as well as the end product. Favorable government mandates and rising quality control standards will flourish the segment expansion in the years ahead.
Concerning the end-use, contract manufacturing organizations are likely to experience decent progression during the forecast period. Contract manufacturing is an agreement between a contract manufacturer and a hiring organization to handle the latter's goods production and shipment. These firms are capable of delivering high-quality products while saving a lot of expenditure on labor, machinery, time, and resources. They provide industry-specific solutions and faster delivery to the market, making them an ideal choice for small businesses and startups.
North America and APAC are anticipated to register commendable progression in the bioburden testing market. Proliferating healthcare sector driven by the rising government investment to improve the infrastructure will increase the medical expenditure of people in the region. The presence of major market players leading to technological advancement and new product innovations may further fuel the industry value.
Developing healthcare infrastructure and rising quality control standards will augment the market revenue during the forecast timeframe. Emerging pharmaceutical and biotechnology industries leading to collaborations and R&D investment and activities may further change the market outlook in the coming years.
Eminent players of the market include Merck KGaA, Charles River, SGS SA, Becton, WuXi AppTec, Dickinson and Company, Thermo Fisher Scientific, NAMSA, Pacific BioLabs, and biomérieux SA. These leaders are implementing strategies like new product innovations, R&D activities, mergers, collaboration, and acquisitions to strengthen their customer base and safeguard their position in the market. In January 2020, Merck launched its latest pharmaceutical bioburden and water testing product, the Milliflex Oasis® System that offers benefits like reduced water decontamination, efficiency, scalability, and operator-independency.
The pandemic aggravated a lot of healthcare and safety concerns among people all over the world, resulting in stringent quality control standards in the manufacturing of essentials like pharmaceuticals, medical equipment, food, and beverages. The rapid upsurge in the production of medical equipment like thermometers, oximeters, nebulizers boosted the demand for bioburden testing. In addition, increasing researches about the virus and vaccines also supported the bioburden testing industry growth and will continue to do so in the coming years.
Market, by Product
Market, by Test
Market, by Application
Market, by End-use
The above information is provided for the following regions and countries: